2014 Webcast

Please see below for the keynote lectures, plenary and oral sessions for the three days of the Congress.

Click either PC or MAC depending on your device.

Thursday 8 May

1330-1340Official Opening and Major HIV Healthcare Issues PC / MAC
Mauro Schechter, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
1340-1410Keynote Lecture – Cascade of Continuous Care in Brazil: Present and
future challenges PC / MAC or Click here to view a summary of this presentation

Fabio Mesquita, Brazilian AIDS programme and Head of the Brazilian Ministry of Health
for HIV/AIDS, Brazil

1410-1430HIV Policy in Central America PC / MAC or Click here to view a summary of this
presentation in English
/ Spanish

Nestor Sosa, Gorgas Memorial Institute, Panama City, Panama
1430-1450Co-morbidities and Ageing in HIV PC / MAC or Click here to view a summary of this
presentation

Peter Reiss, Academic Medical Center, University of Amsterdam, Amsterdam,
The Netherlands

1450-1510Questions and answers PC / MAC

1510-1620HIV and Tuberculosis
1510-1540Keynote Lecture – The Gaps and Successes of TB Control: The GHESKIO experience in Haiti PC / MAC or Click here to view a summary of this presentation
Jean Pape,Center for Global Health, Division of Infectious Diseases, Weill Cornell Medical College, Cornell University, New York, USA and Les Centres GHESKIO, Port-au-Prince, Haiti
1540-1600TB Prevention and Care PC / MAC
Omar Sued, Fundación Huésped, Buenos Aires, Argentina
1600-1620Panel discussion PC / MAC

1620-1640Coffee

1640-1740Treatment Strategies
1640-1700The HIV Treatment Response Prediction System: using the experience of treating tens of thousands of patients to guide optimal drug selection PC / MAC
Brendan Larder,
HIV Resistance Response Database Initiative, London, UK
1700-1720STaR: Single Tablet Regimen RPV/FTC/TDF is safe and well tolerated compared to EVF/FTC/TDF in ART naïve Latinos at week 96 PC / MAC
Trevor Hawkins, Southwest Care Center, Infectious Diseases, Santa Fe, USA
1720-1740Clinical outcomes with first-line antiretroviral therapy in Latin America: analysis from the LATINA Retrospective Cohort PC / MAC
Waldo Belloso, Hospital Italiano and CICAL, Infectious Diseases Unit, Buenos Aires, Argentina

1800-1900GSK/ViiV Healthcare Satellite Symposium
Opening
Isidoro Prudente, ViiV Healthcare Latin America
Study sailing
Luiz Carlos Pereira Junior, Infectious Diseases Emilio Ribas; Rio de Janeiro, Brazil
Tivicay® (dolutegravir): science update
Roberto Zajdenverg, Medical Infectologist. Member of the Brazilian Society of
Infectious Diseases (SBI). Medical Manager of GSK/ViiV Healthcare

Friday 9 May

0900-1000Challenging the Standard Treatment Paradigm:Future Trends in ARV Treatment –
AbbVie Satellite Symposium

Welcome and Introduction
Pedro Cahn Fundación Huésped, Buenos Aires, Argentina
Prevention and Management of ARV Long-term Complications
Estavao Nunes Portela, Instituto de Pesquisa Clínica Evandro Chagas, Rio de Janeiro,
Brazil

Dual Therapy
Anton Pozniak, Chelsea and Westminster Hospital, London, UK

1000-1020Coffee

1020-1220MTCT, Adolescents and HIV in Women
1020-1050Keynote Lecture – Progress and Challenges in Prevention of Perinatal
Transmission PC / MAC or Click here for a summary of this presentation
Lynne Mofenson, Eunice Kennedy Shriver National Institute of Child Health and Human
Development, National Institute of Health, Bethesda, USA
1050-1110Challenges in the prevention of perinatal HIV infection in Latin America
PC / MAC  or Click here for a summary of this presentation in Spanish

Rosa Bologna, Hospital de Pediatria Dr JP Garrahan, Buenos Aires, Argentina
1110-1130A view on pregnancy among HIV perinatally infected adolescents PC / MAC
or Click here to view a summary of this presentation

Marinella della Negra, Instituto de Infectologia Emílio Ribas, São Paulo, Brazil
1130-1145Non-infectious diseases in perinatally HIV-infected children and adolescents from Latin America and the Caribbean PC / MAC
Daisy Maria Machado, Universidade Federal de São Paulo, São Paulo, Brazil
1145-1205Correlation of access to care, VL, and CD4 count with health related quality of life (HRQoL) in HIV-1 infected women: access supports better outcomes
PC / MAC

Jose Valdez Ramalho Madruga, Centro de Referencia e Treinamento DST/AIDS, São Paulo, Brazil
1200-1220Panel discussion PC / MAC

1220-1320Lunch and Posters

1320-1420Treatment as Prevention
1320-1340The Role of ART in Preventing HIV Infections within MSM Populations PC / MAC
Andrew Phillips, University College London, London, UK
1340-1400Pre-exposure Prophylaxis PC / MAC

Jorge Sanchez, Asociacion Civil IMPACTA Salud y Educacion, Lima, Peru
1400-1420Panel discussion PC / MAC
Presenters joined by Beatriz Grinsztejn, Institute of Clinical Research Evandro Chagas,
Rio de Janeiro, Brazil

1420-1440Coffee

1440-1610HIV and Co-morbidities
Case study session co-ordinated by Marcelo Losso, HIV Services, Hospital General de Agudos JM Ramos Mejia, Buenos Aires, Argentina
Cases will include:
Cardiovascular
Nephrology
Neurology

1610-1630Coffee

1630-1730The Evolution of Antiretroviral Therapy
Gilead Satellite Symposium

ART: a brief history
Mauro Schechter, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
The impact of adherence on resistance
Daniel Kuritzkes, Harvard Medical School and Division of Infectious Disease,
Brigham Women’s Hospital, Boston, USA
STRs: the missing link?
Mark Nelson, Chelsea and Westminster Hospital, London, UK
Questions and Answers

1730-1830Scientific Poster Reception

1830-1930New Regimen Comparisons; Individualizing Treatment
MSD Evening Symposium

New regimen comparisons
Luis Soto-Ramírez, Molecular Virology Unit, National Institute of Medical Sciences and
Nutrition, Mexico City, Mexico

Treatment individualization
Carlos Beltran, Hospital Barros Luco Trudeau and Universidad de Santiago,
Santiago, Chile
 

Saturday 10 May

0900-0940Important Advances in the Last Year, including Highlights from the 21st Conference on Retroviruses and Opportunistic Infections (CROI)
0900-0920Luis Soto-Ramirez, Molecular Virology Unit, National Institute of Medical Sciences and Nutrition, Mexico City, Mexico PC / MAC
0920-0940Pedro Cahn, Fundación Huésped, Buenos Aires, Argentina PC / MAC

0940-1010Coffee

1010-1120Vulnerable Populations
1010-1030Managing drug abuse and alcohol use disorders in patients living with HIV/AIDS
PC / MAC

Frederick Altice, Yale University, Yale, USA
1030-1045Epidemiological characteristics of attendants of VCT in the context of faster and integral diagnosis of HIV/STI in Condesa Clinic, Mexico City PC / MAC
Luis Juarez, Codensa, HIV Laboratory, Mexico City, Mexico
1045-1100Late diagnosis in Mexico and its behaviour in time PC / MAC
Adriana Villafuerte, Centro Nacional para la Prevencion y Control del VIH y el Sida, Mexico City, Mexico
1100-1120Panel discussion PC / MAC

1120-1220HIV/HCV co-infection
1120-1140HIV and Hepatitis: What’s new? PC / MAC or Click here to view a summary of this
presentation

Mark Nelson, Chelsea and Westminster Hospital, London, UK
1140-1200HCV Treatment Access for HIV Co-infected Patients in Latin America PC / MAC
Juan Sierra-Madero, National Institute of Medical Sciences and Nutrition, Mexico City,
Mexico

1200-1220Panel discussion PC / MAC

1220-1320Lunch and Posters

1320-1450ART: What’s Next?
1320-1340Resistance Measurement: What’s on the horizon for clinicians? PC / MAC or Click here to view a summary of this presentation
Ricardo Sobhie Diaz, Infectious Diseases Division, Paulista School of Medicine,
Federal University of São Paulo and Retrovirology Laboratory, São Paulo, Brazil

1340-1400Antiretrovirals: New drugs and new strategies PC / MAC or Click here to view a
summary of this presentation

Anton Pozniak, Chelsea and Westminster Hospital, London, UK
1400-1420How are Generics Shaping ARV Use in Latin America? PC / MAC
Massimo Ghidinelli, HIV Unit, PAHO WHO Regional Office, Washington DC, USA
1420-1450Panel discussion PC / MAC

1450-1550Keynote Lectures
Welcome PC / MAC
1450-1520Treatment of Acute HIV Infection PC / MAC
Roy Gulick, Weill Medical College of Cornell University, New York, USA
1520-1550Progress in HIV Cure Research 
Ricardo Sobhie Diaz, Infectious Diseases Division, Paulista School of Medicine,
Federal University of São Paulo and Retrovirology Laboratory, São Paulo, Brazil

1550-1600Official Close PC / MAC
Juan Sierra-Madero, National Institute of Medical Sciences and Nutrition, Mexico City,
Mexico